About Zinc finger protein 107
Zinc finger protein 107 (ZNF107) is a protein
from Homo sapiens identified by UniProt accession
Q9UII5, 783 residues long.
MolForge cross-references it against 0 known binders and
19 disease associations.
Target properties
| Protein name | Zinc finger protein 107 |
|---|
| UniProt accession | Q9UII5 |
|---|
| Gene | ZNF107 |
|---|
| Organism | Homo sapiens |
|---|
| Length | 783 residues |
|---|
| Molecular weight | — |
|---|
| EC numbers | — |
|---|
| Target class | UNCLASSIFIED |
|---|
| Subcellular location | — |
|---|
| Keywords | — |
|---|
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
|---|
| Druggability score | — |
|---|
| Pocket score | — |
|---|
| Max clinical phase | — |
|---|
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
|---|
| AF-Q9UII5-F1 | alphafold | PREDICTED | 74.25 | — |
Amino-acid sequence (783 residues)
MVAKPPVMSF HFAQDLWPEQ NIKDSFQKVT LRRYGKCEYE NLQLRKGCKH VDECTGHKGG HNTVNQCLTA TPSKIFQCNK YVKVFDKFSN SNRYKRRHTG NKHFKCKECS KSFCVLSQLT QHRRIHTRVN SYKCEECGKA FNWFSTLTKH KRIHTGEKPY KCEECGKAFN QSSQLTRHKI IHTEEKPNKC EECGKAFKQA SHLTIHKIIH TGEKPYKYEE CGKVFSQSSH LTTQKILHTG ENLYKCKECG KAFNLFSNLT NHKRIHAGEK PYKCKECGRA FNISSNLNKQ EKIHTGGKLN KCEECDKAFN RSLKLTAHKK ILMEEKPYKC EECGKVFNQF STLTRHKIIH TGEKPYKCKE CGKAFNQSSN LTEHKKIHTA EKSYKCEECG KAFNQHSNLI NHRKIYSGEK PYKCEECGKA FNRSSTLTRH KKIHTGEKPY KCEECDRAFS QSSNLTEHKK IHTGEKPYKC EECGKAFNRF STLTKHKRIH TGEKPYKCEE CGKAFNQSYQ LTRHKIVHTK EKLNKCEEFG KAFKQSSHRT IHKIIHTGEK PYKCEEHGKV FNQSSNLTTQ KIIHTGENLY KFEEHGKAFN LFSNITNHKI IYTGEKPHKC EECGKAYNRF SNLTIHKRIH TGEKPYQCAE CGKAFNCSST LNRHKIIHTG EKPYKCKECG KAFNLSSTLT AHKKIHTGEK PYKCEECGKA FNQSSNLTTH KKIHTSEKPY KCEECGKSFN QFSSLNIHKI IHTGEKPYKC GDYGRAFNLS SNLTTHKKIH TGEKPYKCEY GKT
Explore Zinc finger protein 107 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets